Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
about
Soluble epoxide hydrolase: A potential target for metabolic diseasesEpoxyeicosatrienoic acids, hypertension, and kidney injuryA dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty ratThe 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic painRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceEpoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition.Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.Post-Natal Inhibition of NF-κB Activation Prevents Renal Damage Caused by Prenatal LPS Exposure.Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase.Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order BrassicalesSoluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy.An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease.Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.
P2860
Q28270454-261B7D6E-1012-4778-A559-A0634DAB4648Q28387823-91505D14-73DB-4D2B-A7EB-6A1C22B4E564Q28390006-4FD3E346-FE70-4556-8D2C-FC6A437194ABQ28392416-3FB7EA1C-D1FB-43B4-9EF9-3717C5BD41BCQ28398028-40ED4826-D68C-4658-9A68-904D18CE8F07Q33854978-1C13A507-64AD-432C-94D9-7348F5BF15E5Q35061561-1D89A90C-A6DE-4E4D-8127-7995D52AAA65Q35115765-15B70B04-E40F-4B56-9082-ADFD29B903D5Q35988294-6AF17DBE-5513-4890-9A6F-50A3C78FF277Q35992841-56C2761F-7D34-4E9D-825F-86169B0B805CQ36362984-AD124A8B-B29C-4CFD-A183-C5B51431BB48Q36535579-C879BFBB-08C7-4C14-BC55-BEB62451D320Q37565264-118948A9-9F6B-4FB3-B666-69C25CF9C678Q38605323-954B3299-0942-441D-A39F-EA16501BD100Q38652820-4044B276-C8A9-418D-AEF1-FC13BE141198Q39644067-4C4F740D-C817-4C9D-B1F0-7C3F8FB330A8Q45990632-A170CD44-F976-426C-B19F-8A586B0A4DB8Q46723438-706EE4CF-EE1A-454C-B465-E2F1100C1233Q47148741-272E61D7-296C-498F-87A7-C2B3B242423FQ50326733-882C978E-41E1-4676-AFE8-6F215F2743FFQ51741240-F248230D-5A1C-432D-A1B8-BFA2E5D4D232Q52674866-F7E05A05-5638-46D3-90A5-7BC6E72EA2C1
P2860
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@ast
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@en
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@nl
type
label
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@ast
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@en
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@nl
prefLabel
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@ast
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@en
Inhibition of soluble epoxide ...... ial fibrosis and inflammation.
@nl
P2860
P50
P1476
Inhibition of soluble epoxide ...... tial fibrosis and inflammation
@en
P2093
Babu J Padanilam
Bruce D Hammock
P2860
P304
P356
10.1152/AJPRENAL.00256.2014
P577
2014-08-27T00:00:00Z